Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P060004/S010

MEL 90 Excimer Laser

Carl Zeiss Meditec, Inc. · Decision date Jul 1, 2026

FDA DECISIONP060004/S010

What did the FDA approve?

FDA records P060004/S010 as a supplement to PMA P060004, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Jul 1, 2026.

FDA approval order statement

new replacement infrared (IR) light-emitting diodes (LEDs) with subsequent changes to the IR LED Power Supply Printed Circuit Board Assembly (PCBA)
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Ophthalmic
Decision date
Jul 1, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P060004/S010
Regulatory pathway
PMA supplement
Product code
LZS
Decision code
APPR
Decision date
Jul 1, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Excimer laser system.

Product code
LZS
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P060004/S010 received

    Application receipt date recorded by FDA.

  2. P060004/S010 · FDA decision

    Real-Time Process

Timeline entries are records held by MedtechLedger for P060004. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P060004

Product / regulatory recordCompanyPathwayDecision dateSource
Carl Zeiss Meditec, Inc.PMA supplementApr 30, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Carl Zeiss Meditec, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
5160 Hacienda Dr., Dublin, CA, 94568

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records